Van Broeck; Didier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Broeck; Didier.The latest application filed is for "substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same".

Company Profile

0.16.3

Van Broeck; Didier - Paris FR
Van Broeck; Didier - Juvignac FR
Van Broeck, Didier - Murviel Les Montpellier FR
Van Broeck; Didier - Murviel les Montpellier par Pignan FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same Grant 7,915,258 - Congy , et al. March 29, 2	2011-03-29
(1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics Grant 7,632,852 - Barth , et al. December 15, 2	2009-12-15
Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one Derivatives, Preparation Thereof And Therapeutic Use Of The Same App 20090281107 - CONGY; Christian ; et al.	2009-11-12
(1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole Derivatives, Preparation Method Thereof And Use Of Same In Therapeutics App 20080039510 - BARTH; Francis ; et al.	2008-02-14
Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them App 20040220223 - Bichon, Daniel ; et al.	2004-11-04
Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them Grant 6,710,042 - Bichon , et al. March 23, 2	2004-03-23
Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present Grant 6,242,637 - Emonds-Alt , et al. June 5, 2	2001-06-05
Use of amines to produce drugs for preventing tumor cell proliferation Grant 6,235,791 - Breliere , et al. May 22, 2	2001-05-22
Compounds which are selective antagonists of the human NK.sub.3 receptor and their use as medicinal products and diagnostic tools Grant 5,942,523 - Bichon , et al. August 24, 1	1999-08-24
Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present Grant 5,780,466 - Emonds-Alt , et al. July 14, 1	1998-07-14
Compounds which are selective antagonists of the human NK.sub.3 receptor and their use as medicinal products and diagnostic tools Grant 5,741,910 - Bichon , et al. April 21, 1	1998-04-21
Substituted heterocyclic compounds and pharmaceutical compositions in which they are present Grant 5,641,777 - Emonds-Alt , et al. June 24, 1	1997-06-24
Process for preparing N-alkylene piperidino compounds and their enantiomers Grant 5,606,065 - Emonds-Alt , et al. February 25, 1	1997-02-25
1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present Grant 5,583,134 - Emonds-Alt , et al. December 10, 1	1996-12-10
N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions Grant 5,411,971 - Edmonds-Alt , et al. May 2, 1	1995-05-02
Arylalkylamines, process for preparing them and pharmaceutical compositions containing them Grant 5,350,852 - Emonds-Alt , et al. September 27, 1	1994-09-27
Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them Grant 5,300,648 - Emonds-Alt , et al. April 5, 1	1994-04-05
Arylalkylamines, process for preparing them and pharmaceutical compositions containing them Grant 5,236,921 - Emonds-Ai , et al. August 17, 1	1993-08-17
1-(benzylpiperidino)propan-2-ol derivatives, their preparation, their use as antimicrobial agents and the products in which they are present Grant 5,036,077 - Van Broeck , et al. July 30, 1	1991-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.